Hong Kong Investment Corporation
Overview
The Hong Kong Investment Corporation Limited (“HKIC”) is wholly owned by the Government of the Hong Kong Special Administrative Region (“HKSARG”). As Patient Capital, we carry a dual mandate - seeking reasonable financial return over the medium to long term, and more importantly, enhancing the long-term competitiveness and economic vitality of Hong Kong. We play an important role in curating synergy among the HKSARG, industry, academia, research and investment sectors. Size of our initial capital for deployment is HK$62 billion, covering the “Hong Kong Growth Portfolio”, “Greater Bay Area Investment Fund”, “Strategic Tech Fund”, and “Co-Investment Fund”. Currently, our key investment themes are Hard & Core Technology, Biotechnology, and New Energy & Green Technology, and the relevant applications.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EnerVenue | Mar 2026 | Series B Extension | Co-investor |
| Cornerstone Robotics | Nov 2025 | Early Funding | Lead |
| RushOwl | Sep 2025 | Series A | Co-investor |
| WeLab | Apr 2025 | Strategic | Lead |
| Ainfinity Semiconductor | Feb 2025 | Angel | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.